Our results provide a new understanding of the role and mechanism of the LINC00470/miR‐134/MYC/ABCC1 axis in glioma, which may contribute to the development of novel therapeutic targets and improve the chemosensitivity of glioma. This evidence concerns the gene MYC and central nervous system cancer.